UCB have appointed Steve Turley as managing director for the British and Irish isles.
Turley will also be an important figure in UCB’s European Leadership Team and will report to Khoso Baluch, head of EMEA Operations.
Turley joins from Lundbeck and brings with him over 20 years of experience in the pharmaceutical industry at Merck Sharp & Dohme, Roche and Actelion. He has worked across a range of therapy areas at both local and international levels.
He said: “I am pleased to be joining a dynamic business that is focused on delivering medicines that really deliver for patients.
“I am looking forward to building on that with our team here in BII.”